1000339-10-5
1000339-10-5 结构式
基本信息
2-甲氧基-5-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)苯胺
2-甲氧基-5-(4,4,5,5-四甲基-1,3,2-二氧杂环戊硼烷-2-基)苯胺
2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenamine
Benzenamine, 2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
物理化学性质
制备方法
6358-77-6
73183-34-3
1000339-10-5
一般步骤:以5-溴-2-甲氧基苯胺(3.22g,15.93mmol)和联硼酸频那醇酯(8.1g,31.86mmol)为原料,在氮气保护下,向反应瓶中加入乙酸钾(8.9g,90.83mmol)、双(二苯基膦)二茂铁二氯化钯(II)(0.34g,0.48mmol)及无水DMSO(40mL)。反应混合物在80℃下搅拌8小时。反应完成后,用饱和NaCl水溶液(30mL)淬灭反应,并用乙醚(3×20mL)萃取。合并有机相,用硫酸镁干燥,过滤后浓缩。粗产物通过快速柱色谱法纯化(固定相:硅胶230-400目,流动相:9:1己烷/乙酸乙酯)。收集所有均匀的级分,浓缩后得到目标产物2-甲氧基-5-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)苯胺(3.18g,产率80%),为棕色浆状物。νmax(DCM)/cm?1:2926.38, 1599.02, 1431.11, 1356.01, 1221.39, 1142.48。1H NMR(CDCl?, 400MHz)δH ppm:1.35(12H, s, 2*C(CH?)?),3.89(3H, s, OCH?),6.15(2H, br, NH?),7.18(1H, d, J=8.0Hz, ArH),7.25(1H, d, J=2.5Hz, ArH),7.29(1H, s, ArH)。13C NMR δC ppm:24.5(4*CH?),55.1(OCH?),83.2(2*C(CH?)?),105.5(ArCH),113.7(ArC),120.6(ArCH),125.8(ArCH),135.0(ArC),149.7(ArC)。
参考文献:
[1] Patent: US2015/18566, 2015, A1. Location in patent: Paragraph 0685; 0686; 0687; 0688; 0689
[2] Journal of Medicinal Chemistry, 2015, vol. 58, # 9, p. 3767 - 3793
[3] Patent: US2016/318895, 2016, A1. Location in patent: Paragraph 0303